

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in alcoholic hepatitis | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-97/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-97" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in alcoholic hepatitis" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in alcoholic hepatitis.">
            <meta name="og:description" content="Read the latest article version by Vikrant Rachakonda, Ramon Bataller, Andres Duarte-Rojo, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="22413">
            <meta name="article-id" content="20394">
            <meta name="dc.title" content="Recent advances in alcoholic hepatitis">
            <meta name="dc.description" content="Alcoholic hepatitis is the severest clinical presentation of alcoholic liver disease. Lacking an effective pharmacologic treatment, alcoholic hepatitis is associated with a poor prognosis and its recovery relies mostly on abstinence. With alcohol use disorder being universally on the rise, the impact of alcoholic hepatitis on society and health-care costs is expected to increase significantly. Prognostic factors and liver biopsy can help with timely diagnosis, to determine eligibility and response to corticosteroids, and for prognostication and transplant referral. Although recent discoveries in the pathophysiology of alcoholic hepatitis are encouraging and could pave the way for novel treatment modalities, a multidisciplinary approach considering timely identification and treatment of liver-related complications, infectious and metabolic disease, malnutrition, and addiction counseling should be emphasized. Apart from proper selection of candidates, transplant programs should provide adequate post-transplant addiction support in order to make of early liver transplantation for alcoholic hepatitis the ultimate sobering experience in the next decade.">
            <meta name="dc.subject" content="addiction, corticosteroids, biomarkers, liver transplantation">
            <meta name="dc.creator" content="Rachakonda, Vikrant">
            <meta name="dc.creator" content="Bataller, Ramon">
            <meta name="dc.creator" content="Duarte-Rojo, Andres">
            <meta name="dc.date" content="2020/02/10">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.20394.1">
            <meta name="dc.source" content="F1000Research 2020 9:97">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="addiction">
            <meta name="prism.keyword" content="corticosteroids">
            <meta name="prism.keyword" content="biomarkers">
            <meta name="prism.keyword" content="liver transplantation">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/02/10">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="97">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.20394.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-97">
            <meta name="citation_title" content="Recent advances in alcoholic hepatitis">
            <meta name="citation_abstract" content="Alcoholic hepatitis is the severest clinical presentation of alcoholic liver disease. Lacking an effective pharmacologic treatment, alcoholic hepatitis is associated with a poor prognosis and its recovery relies mostly on abstinence. With alcohol use disorder being universally on the rise, the impact of alcoholic hepatitis on society and health-care costs is expected to increase significantly. Prognostic factors and liver biopsy can help with timely diagnosis, to determine eligibility and response to corticosteroids, and for prognostication and transplant referral. Although recent discoveries in the pathophysiology of alcoholic hepatitis are encouraging and could pave the way for novel treatment modalities, a multidisciplinary approach considering timely identification and treatment of liver-related complications, infectious and metabolic disease, malnutrition, and addiction counseling should be emphasized. Apart from proper selection of candidates, transplant programs should provide adequate post-transplant addiction support in order to make of early liver transplantation for alcoholic hepatitis the ultimate sobering experience in the next decade.">
            <meta name="citation_description" content="Alcoholic hepatitis is the severest clinical presentation of alcoholic liver disease. Lacking an effective pharmacologic treatment, alcoholic hepatitis is associated with a poor prognosis and its recovery relies mostly on abstinence. With alcohol use disorder being universally on the rise, the impact of alcoholic hepatitis on society and health-care costs is expected to increase significantly. Prognostic factors and liver biopsy can help with timely diagnosis, to determine eligibility and response to corticosteroids, and for prognostication and transplant referral. Although recent discoveries in the pathophysiology of alcoholic hepatitis are encouraging and could pave the way for novel treatment modalities, a multidisciplinary approach considering timely identification and treatment of liver-related complications, infectious and metabolic disease, malnutrition, and addiction counseling should be emphasized. Apart from proper selection of candidates, transplant programs should provide adequate post-transplant addiction support in order to make of early liver transplantation for alcoholic hepatitis the ultimate sobering experience in the next decade.">
            <meta name="citation_keywords" content="addiction, corticosteroids, biomarkers, liver transplantation">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Vikrant Rachakonda">
            <meta name="citation_author_institution" content="Division of Gastroenterology and Hepatology, Starzl Transplantation Institute, and Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, 15213, USA">
            <meta name="citation_author" content="Ramon Bataller">
            <meta name="citation_author_institution" content="Division of Gastroenterology and Hepatology, Starzl Transplantation Institute, and Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, 15213, USA">
            <meta name="citation_author" content="Andres Duarte-Rojo">
            <meta name="citation_author_institution" content="Division of Gastroenterology and Hepatology, Starzl Transplantation Institute, and Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, 15213, USA">
            <meta name="citation_publication_date" content="2020/02/10">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="97">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.20394.1">
            <meta name="citation_firstpage" content="97">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-97/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-97.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=22413 /> <input type=hidden id=articleId name=articleId value=20394 /> <input type=hidden id=xmlUrl value="/articles/9-97/v1/xml"/> <input type=hidden id=xmlFileName value="-9-97-v1.xml"> <input type=hidden id=article_uuid value=6062ef8c-8239-4c05-b625-ea3134cb710f /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in alcoholic hepatitis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.20394.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.20394.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-97"
  },
  "headline": "Recent advances in alcoholic hepatitis",
  "datePublished": "2020-02-10T09:57:37",
  "dateModified": "2020-02-10T09:57:37",
  "author": [
    {
      "@type": "Person",
      "name": "Vikrant Rachakonda"
    },    {
      "@type": "Person",
      "name": "Ramon Bataller"
    },    {
      "@type": "Person",
      "name": "Andres Duarte-Rojo"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Alcoholic hepatitis is the severest clinical presentation of alcoholic liver disease. Lacking an effective pharmacologic treatment, alcoholic hepatitis is associated with a poor prognosis and its recovery relies mostly on abstinence. With alcohol use disorder being universally on the rise, the impact of alcoholic hepatitis on society and health-care costs is expected to increase significantly. Prognostic factors and liver biopsy can help with timely diagnosis, to determine eligibility and response to corticosteroids, and for prognostication and transplant referral. Although recent discoveries in the pathophysiology of alcoholic hepatitis are encouraging and could pave the way for novel treatment modalities, a multidisciplinary approach considering timely identification and treatment of liver-related complications, infectious and metabolic disease, malnutrition, and addiction counseling should be emphasized. Apart from proper selection of candidates, transplant programs should provide adequate post-transplant addiction support in order to make of early liver transplantation for alcoholic hepatitis the ultimate sobering experience in the next decade."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-97",
            "name": "Recent advances in alcoholic hepatitis"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in alcoholic hepatitis </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=22413 data-id=20394 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20394.1" data-recommended="" data-doi="10.12688/f1000research.20394.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-97/v1/pdf?article_uuid=6062ef8c-8239-4c05-b625-ea3134cb710f" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-20394-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-20394-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-20394-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Rachakonda V, Bataller R and Duarte-Rojo A. Recent advances in alcoholic hepatitis [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):97 (<a class=new-orange href="https://doi.org/10.12688/f1000research.20394.1" target=_blank>https://doi.org/10.12688/f1000research.20394.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-20394-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=20394 id=track-article-signin-20394 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20394?target=/articles/9-97">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22413 /> <input name=articleId type=hidden value=20394 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in alcoholic hepatitis</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Vikrant Rachakonda,&nbsp;</span><span class="">Ramon Bataller,&nbsp;</span><span class=""><a href="mailto:duarterojoa@upmc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Andres Duarte-Rojo</span></a><a href="https://orcid.org/0000-0002-5377-9295" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5377-9295</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Vikrant Rachakonda,&nbsp;</span><span class="">Ramon Bataller,&nbsp;</span><span class=""><a href="mailto:duarterojoa@upmc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Andres Duarte-Rojo</span></a><a href="http://orcid.org/0000-0002-5377-9295" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5377-9295</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 10 Feb 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.20394.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Division of Gastroenterology and Hepatology, Starzl Transplantation Institute, and Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, 15213, USA<br/> <p> <div class=margin-bottom> Vikrant Rachakonda <br/> <span>Roles: </span> Conceptualization, Investigation, Writing  Original Draft Preparation </div> <div class=margin-bottom> Ramon Bataller <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Andres Duarte-Rojo <br/> <span>Roles: </span> Conceptualization, Investigation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=63535-59592></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=63533-59594></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=63539-59593></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Alcoholic hepatitis is the severest clinical presentation of alcoholic liver disease. Lacking an effective pharmacologic treatment, alcoholic hepatitis is associated with a poor prognosis and its recovery relies mostly on abstinence. With alcohol use disorder being universally on the rise, the impact of alcoholic hepatitis on society and health-care costs is expected to increase significantly. Prognostic factors and liver biopsy can help with timely diagnosis, to determine eligibility and response to corticosteroids, and for prognostication and transplant referral. Although recent discoveries in the pathophysiology of alcoholic hepatitis are encouraging and could pave the way for novel treatment modalities, a multidisciplinary approach considering timely identification and treatment of liver-related complications, infectious and metabolic disease, malnutrition, and addiction counseling should be emphasized. Apart from proper selection of candidates, transplant programs should provide adequate post-transplant addiction support in order to make of early liver transplantation for alcoholic hepatitis the ultimate sobering experience in the next decade. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> addiction, corticosteroids, biomarkers, liver transplantation </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Andres Duarte-Rojo (<a href="mailto:duarterojoa@upmc.edu">duarterojoa@upmc.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Andres Duarte-Rojo </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Work by RB is supported by the National Institute on Alcohol Abuse and Alcoholism [1U01AA026978-01, 1U01AA026972-01, 1U01AA026264-01]. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2020 Rachakonda V <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Rachakonda V, Bataller R and Duarte-Rojo A. Recent advances in alcoholic hepatitis [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):97 (<a href="https://doi.org/10.12688/f1000research.20394.1" target=_blank>https://doi.org/10.12688/f1000research.20394.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 10 Feb 2020, <b>9</b>(F1000 Faculty Rev):97 (<a href="https://doi.org/10.12688/f1000research.20394.1" target=_blank>https://doi.org/10.12688/f1000research.20394.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 10 Feb 2020, <b>9</b>(F1000 Faculty Rev):97 (<a href="https://doi.org/10.12688/f1000research.20394.1" target=_blank>https://doi.org/10.12688/f1000research.20394.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d56525e146>Introduction</h2><p class="" id=d56525e149>Alcoholic hepatitis (AH) is a life-threatening form of acute-on-chronic liver failure that occurs in patients with sustained heavy alcohol use. AH is characterized by a rapid onset or worsening of jaundice, liver synthetic dysfunction, and features of hepatic decompensation, including ascites, encephalopathy, and portal hypertensive bleeding. An episode of AH is frequently the first clinical presentation of alcohol-related liver disease, and in patients with severe disease, prognosis is poor; mortality is 20 to 50% at 28 days and up to 70% at 90 days<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. Pharmacotherapy for AH remains limited to corticosteroids; however, almost half of patients cannot tolerate or do not respond to corticosteroid therapy. The only intervention shown to improve long-term survival in AH is alcohol abstinence, thus highlighting a critical role for multidisciplinary care incorporating mental health and addiction teams. More recently, early liver transplantation (LT) has been used in carefully selected populations showing 3-year survival rates equivalent to those for other chronic liver diseases; concerns regarding post-transplant alcohol relapse, however, have limited acceptance of early transplantation as standard treatment.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d56525e162>Epidemiology of alcoholic hepatitis</h2><p class="" id=d56525e165>The epidemiology of AH is poorly understood, particularly in the US, where liver biopsy is rarely performed for this condition. Trends in patterns of alcohol use, however, suggest that AH incidence rates are likely to increase in Western nations. Recent US reports on the impact of state alcohol sales policies have highlighted increased rates of alcohol consumption<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Furthermore, drinking at an earlier age<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup> and binging patterns of use have dramatically increased in the last decade<sup><a href="#ref-7">7</a></sup>. These behaviors have translated into increased mortality related to alcoholic liver disease; from 2009 to 2016, Americans 25 to 34 years old experienced the greatest increase in liver-related mortality among all age groups and this increase was driven entirely by alcoholic liver disease<sup><a href="#ref-8">8</a></sup>. Although a significant proportion of these deaths are likely attributable to AH, no US studies have systematically explored the epidemiology of AH. In a Danish national cohort study, the incidence of AH rose from 24 to 34 per million women and from 37 to 46 per million men between 1999 and 2008<sup><a href="#ref-9">9</a></sup>, and it is likely that similar trends have occurred in other Western nations.</p><p class="" id=d56525e194>With the changing epidemiology of alcohol use and alcohol-related liver disease, the health-care and economic burden of AH has increased over the last decade. For example, an analysis of the Nationwide Inpatient Sample demonstrated increased rates of hospitalization for AH from 2002 to 2010<sup><a href="#ref-10">10</a></sup>. While there was a significant decline in inpatient mortality due to AH (4.3% absolute risk reduction), the cost of hospitalization increased by 41%<sup><a href="#ref-10">10</a></sup>. Another report showed a 96% increase in the inpatient cost of care for alcoholic cirrhosis between 2002 and 2014, representing almost 50% of the total inpatient charges for cirrhosis<sup><a href="#ref-11">11</a></sup>. As length of stay remained unchanged over the studied time frame for both studies, increased costs likely represent an absolute increase in resource utilization.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d56525e212>Pathophysiology of alcoholic hepatitis</h2><p class="" id=d56525e215>AH is driven by both intra- and extra-hepatic effects of alcohol. Within hepatocytes, alcohol is degraded into the toxic metabolite acetaldehyde via non-inducible (alcohol dehydrogenase) and inducible (CYP2E1) enzymes. In addition to acetaldehyde, multiple reactive oxygen intermediates (ROIs) are generated by CYP2E1. Acetaldehyde directly induces hepatocyte death through both necrosis and apoptosis, and hepatocyte injury leads to release of damage-associated molecular patterns (DAMPs). DAMPs subsequently bind to Toll-like receptors (TLRs) in Kupffer cells, the resident tissue macrophage of the liver, leading to activation of the inflammasome, a multiprotein complex containing caspase 1. Upon inflammasome activation, caspase 1 generates the pro-inflammatory cytokine interleukin 1 beta (IL-1)<sup><a href="#ref-12">12</a><a href="#ref-14">14</a></sup>.</p><p class="" id=d56525e225>Alcohol exerts deleterious intestinal effects, which eventually lead to hepatic inflammation through multiple mechanisms. Particularly, alcohol exerts direct toxicity on intestinal epithelial cells and decreases the expression of tight-junction proteins, which enhances the permeability of the intestinal mucosa, permitting translocation of pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS) into the liver<sup><a href="#ref-15">15</a><a href="#ref-17">17</a></sup>. As with DAMPs, PAMPs can then activate macrophage inflammasomes via TLR, leading to elaboration of multiple inflammatory cytokines (including IL-1B, tumor necrosis factor alpha (TNF-) and IL-10) and neutrophil chemokines (including IL-8, Gro-, CXCL-5, and CXCL-6)<sup><a href="#ref-18">18</a></sup>. The net increase in intra-hepatic inflammation perpetuates further hepatocellular mitochondrial dysfunction, ROI generation, and hepatic failure.</p><p class="" id=d56525e239>In addition to dysregulated hepatic inflammation, multiple clinical observations point to hepatocellular dysfunction and impaired regeneration as critical drivers of liver failure in AH. First, liver explants from AH patients undergoing LT demonstrate near complete loss of hepatocyte proliferation compared with alcoholic cirrhosis and normal liver<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. In addition, hepatocyte proliferation is associated with improved survival in severe AH<sup><a href="#ref-20">20</a></sup>. Finally, patients with AH exhibit a significant expansion of liver progenitor cells (LPCs) (termed ductular reaction) and failure of LPC differentiation into mature hepatocytes correlates with reduced survival<sup><a href="#ref-21">21</a></sup>. To further delineate molecular mechanisms of hepatocellular dysfunction in AH, Argemi <i>et al</i>. performed untargeted RNA sequencing in livers with different alcoholic liver disease phenotypes and identified that development of AH was characterized by defective activity of liver-enriched transcription factors<sup><a href="#ref-22">22</a></sup>. In particular, transforming growth factor beta 1 (TGF-1) was a primary transcriptional regulator in AH and induced fetal isoforms of hepatic nuclear factor 4a (HNF-4a) P2 promoter, resulting in defective hepatic synthetic and metabolic function. Altered expression of HNF-4adependent genes was driven by epigenetic phenomena<sup><a href="#ref-22">22</a></sup>. Together, these findings highlight a critical role for not only intra-hepatic inflammation but also hepatocellular dysfunction and impaired regeneration in the pathogenesis of AH.</p><p class="" id=d56525e269>Recently, genetic predisposition has expanded our understanding of alcoholic liver disease, and some relevant genetic signals are shared with the non-alcoholic steatohepatitis counterpart (for example, patatin-like phospholipase domain-containing protein 3, transmembrane 6 superfamily member 2, and hydroxysteroid 17-beta dehydrogenase 13)<sup><a href="#ref-23">23</a><a href="#ref-25">25</a></sup>. Although the impact of genetic predisposition in AH is less clear, mutations in CYP2E1<sup><a href="#ref-26">26</a></sup> and, more recently, a transcriptome analysis were over-represented in AH or had prognostic implications<sup><a href="#ref-27">27</a></sup>. In the latter, a 123-gene prognostic signature was identified from fixed liver biopsy samples in patients with severe AH and it improved the prediction of transplant-free survival along with the model for end-stage liver disease (MELD). The identified genetic signals corresponded to inflammatory and oxidative stress pathways, intermediate metabolism, and hepatic stellate cells<sup><a href="#ref-27">27</a></sup>.</p><p class="" id=d56525e292>Gut dysbiosis has been involved in the pathophysiology of various chronic liver ailments, including alcoholic liver disease<sup><a href="#ref-28">28</a></sup>. Alcohol directly contributes to intestinal microbial dysbiosis, and in both murine and human studies, alcohol induces shifts in bacterial communities favoring pathogenic species<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. Non-bacterial populations are also affected, as a recent translational study described reduced fungal biodiversity with enhanced anti-fungal immune responses in severe AH<sup><a href="#ref-31">31</a></sup>. Such changes in microbiota break the balance of the gutliver axis either directly through bacterial metabolites or indirectly through TLRs and other signaling molecules (PAMP/DAMP pathways) and activation of the immune system<sup><a href="#ref-32">32</a></sup>. The beneficial effects that modulation of the intestinal flora brings to patients with AH, as observed in pilot trials using either rifaximin or fecal microbiota transplantation, add evidence to support the pivotal role of the gutliver axis and gut eubiosis as a novel therapeutic aim<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d56525e324>Diagnostic and prognostic assessment in alcoholic hepatitis</h2><p class="" id=d56525e327>There are no reliable non-invasive markers for identification of AH and hence the syndrome is most often diagnosed on clinical grounds. The cardinal feature of AH is recent onset of jaundice within 60 days of last alcohol consumption in a patient with known heavy alcohol use for more than 6 months. The diagnosis relies on proving heavy alcohol use as the primary etiology of liver injury while excluding other causes of liver disease. Although minimum alcohol use requirements for AH have not been described, a consumption threshold of at least three drinks (40 g) daily in women or at least four drinks (60 g) daily in men is most commonly used for inclusion in treatment studies in AH. Laboratory features of AH include serum bilirubin of at least 3 mg/dL, aspartate aminotransferase (AST) between 50 and 400 IU/mL, and AST/alanine aminotransferase ratio of at least 1.5.</p><p class="" id=d56525e330>In 2016, an expert panel within the National Institute for Alcohol Abuse and Alcoholism proposed a classification scheme for AH as follows: (1) definite AH: clinical criteria for diagnosis are met and confirmed by liver biopsy; (2) probable AH: clinically diagnosed AH without liver biopsy and without confounding factors; and (3) possible AH: clinically diagnosed AH but with confounding factors, including possible ischemic hepatitis, drug-induced liver injury, atypical laboratory tests, or uncertainty regarding alcohol consumption or a combination of these<sup><a href="#ref-2">2</a></sup>; in this subset, liver biopsy is recommended.</p><p class="" id=d56525e337>In contrast, the European Association for the Study of the Liver recommends liver biopsy for the diagnosis of AH, as the accuracy of clinical diagnosis is around 70 to 80%<sup><a href="#ref-35">35</a></sup>. Typical histologic findings include macrovesicular steatosis, ballooning degeneration of hepatocytes, MalloryDenk bodies, megamitochondria, lobular inflammation with neutrophilic satellitosis, and bilirubinostasis with ductular reaction<sup><a href="#ref-35">35</a><a href="#ref-37">37</a></sup>. Advanced fibrosis is a common feature of AH, and it is estimated that 80% of patients with AH have micronodular cirrhosis<sup><a href="#ref-37">37</a></sup>. Typical fibrosis patterns include centrilobular, pericellular, and sinusoidal fibrosis (chicken wire fibrosis). A landmark study from 2014 demonstrated that, in addition to prognostic information, histology may also provide prognostic value in AH, and a scoring system consisting of fibrosis, bilirubinostasis, neutrophilic infiltration, and megamitochondria demonstrated an area under the receiver operating characteristic curve (AUROC) of 0.77 for 90-day mortality<sup><a href="#ref-37">37</a></sup>. Severe AH was defined as a histologic score of 6 to 9 and was associated with 50% 90-day mortality<sup><a href="#ref-37">37</a></sup>. Interestingly, severity of fibrosis was the strongest negative predictor of survival whereas neutrophilic inflammation was associated with improved survival. Despite the utility of liver biopsy, the presence of coagulopathy, thrombocytopenia, uremia, and ascites in AH generally precludes percutaneous liver biopsy, and transjugular biopsy is not widely available.</p><p class="" id=d56525e363>Several laboratory-based scoring systems have been studied for outcome prediction in AH and these are highlighted in <a href="#T1">Table 1</a>. Historically, the Maddrey discriminant function (MDF) was the most commonly used model to identify candidates for corticosteroid therapy<sup><a href="#ref-38">38</a></sup>. Two major drawbacks of MDF were (1) the use of prothrombin time, which is not standardized between clinical laboratories, and (2) the absence of renal function assessment, as acute kidney injury is a strong predictor of mortality in AH<sup><a href="#ref-39">39</a></sup>. More recently, the MELD score has been used to classify AH patients at high risk of death in need of treatment<sup><a href="#ref-40">40</a></sup>. At a cutoff of at least 21, MELD score exhibited 75% sensitivity and specificity for predicting 90-day mortality. Other models, including the age/bilirubin/international normalized ratio/creatinine (ABIC) score<sup><a href="#ref-41">41</a></sup> and the Glasgow Alcoholic Hepatitis Score (GAHS)<sup><a href="#ref-42">42</a></sup> are less well studied in North American populations. An ABIC score of less than 6.71 has been associated with 100% survival, whereas an ABIC score of more than 9.00 predicts 25% survival at 90 days<sup><a href="#ref-41">41</a></sup>. The GAHS has also been used to identify candidates for corticosteroid therapy, as patients with a GAHS of at least 9 and an MDF of at least 32 exhibited better survival with steroid therapy than without, whereas subjects with a GAHS of less than 9 and an MDF of less than 32 did not benefit from treatment<sup><a href="#ref-43">43</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Prognostic scoring systems for alcoholic hepatitis.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d56525e410 class=n-a></a><thead><a name=d56525e412 class=n-a></a><tr><a name=d56525e414 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e416 class=n-a></a>Score</th><th align=left colspan=4 rowspan=1 valign=top><a name=d56525e419 class=n-a></a>Formula</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e422 class=n-a></a>Interpretation</th></tr></thead><tbody><a name=d56525e427 class=n-a></a><tr><a name=d56525e429 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e431 class=n-a></a>MDF</td><td align=left colspan=4 rowspan=1 valign=top><a name=d56525e434 class=n-a></a>4.6(PT-control PT)+bilirubin (mg/dL)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e437 class=n-a></a>Severe: 32</td></tr><tr><a name=d56525e441 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e443 class=n-a></a>MELD</td><td align=left colspan=4 rowspan=1 valign=top><a name=d56525e446 class=n-a></a>3.8[ln(bilirubin(mg/dL)]+11.2[ln(INR)]+9.6[ln(creatinine(mg/dL)]+6.4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e449 class=n-a></a>Severe: 21</td></tr><tr><a name=d56525e453 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e455 class=n-a></a>ABIC</td><td align=left colspan=4 rowspan=1 valign=top><a name=d56525e458 class=n-a></a>(age0.1)+(bilirubin0.08)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e461 class=n-a></a>Low risk: 6.71<br class=br>Severe: &gt;9.0</td></tr><tr><a name=d56525e467 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e469 class=n-a></a>GAHS</td><td align=left colspan=1 rowspan=1><a name=d56525e472 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e474 class=n-a></a>1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e477 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e480 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e484 class=n-a></a>Severe: 9</td></tr><tr><a name=d56525e488 class=n-a></a><td align=left colspan=1 rowspan=6><a name=d56525e490 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e492 class=n-a></a>Age</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e495 class=n-a></a>&lt;50</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e498 class=n-a></a>50</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e501 class=n-a></a></td><td align=left colspan=1 rowspan=6><a name=d56525e505 class=n-a></a></td></tr><tr><a name=d56525e509 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e511 class=n-a></a>WBC count</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e514 class=n-a></a>&lt;15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e517 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e520 class=n-a></a></td></tr><tr><a name=d56525e524 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e526 class=n-a></a>Urea, mmol/L</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e529 class=n-a></a>&lt;5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e532 class=n-a></a>5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e535 class=n-a></a></td></tr><tr><a name=d56525e539 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e541 class=n-a></a>INR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e544 class=n-a></a>&lt;1.5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e547 class=n-a></a>1.52.0</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e550 class=n-a></a>&gt;2.0</td></tr><tr><a name=d56525e554 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e556 class=n-a></a>Bilirubin, mg/dL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e559 class=n-a></a>&lt;7.3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e562 class=n-a></a>7.414.6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e565 class=n-a></a>&gt;14.6</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=TFN1 class=n-a></a><p id=d56525e575> ABIC, age/bilirubin/international normalized ratio/creatinine; GAHS, Glasgow Alcoholic Hepatitis Score; INR, international normalized ratio; MDF, Maddrey discriminant function; MELD, Model for End-Stage Liver Disease; PT, prothrombin time; WBC, white blood cell.</p></div></div></div><p class="" id=d56525e581>Early observational trials of steroid therapy identified declining bilirubin as a marker of therapeutic response and hence the Lille score was developed to quantify changes in labs over 7 days of steroid treatment. A Lille score of more than 0.45 after 7 days was associated with over 75% 90-day mortality<sup><a href="#ref-44">44</a></sup>. A multinational study reported on a similar accuracy when the Lille score was evaluated at day 4, when compared with the original one after 7 days on corticosteroids<sup><a href="#ref-45">45</a></sup>. Combining MELD and Lille scores increases prognostic accuracy compared with either score alone<sup><a href="#ref-46">46</a></sup>, and various useful combination strategies were recently studied as part of a <i>post hoc</i> analysis of a large multicenter AH clinical trial<sup><a href="#ref-47">47</a></sup>.</p><p class="" id=d56525e603>Given the above limitations of laboratory-based models for outcome prediction in AH, a number of studies have explored novel biomarkers of AH. For example, analysis of circulating exosomes has demonstrated increased enrichment of miR-155 (a key regulator of inflammation), miR-192, and miR-30a in patients with AH compared with controls<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>. Circulating levels of several cytokines, including TNF-, IL-1, IL-6, and IL-8, have also been studied in AH, and elevated serum IL-6 levels, in particular, have shown promise as a marker of increased mortality in patients with an MDF of at least 32<sup><a href="#ref-50">50</a></sup>. More recently, two studies have shown that increased levels of cytokeratin 18 fragments may be used for identification and severity assessment in AH<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>, and urinary metabolomics studies have identified higher levels of urinary acrolein metabolites in severe AH compared with both healthy controls and non-severe disease<sup><a href="#ref-53">53</a></sup>. Finally, an analysis of blood neutrophil/lymphocyte ratio (NLR) demonstrated that NLR was associated with infection, acute kidney injury, and steroid responsiveness<sup><a href="#ref-54">54</a></sup>. Validation and standardization of these promising tools are still needed across multiple clinical settings.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d56525e635>Management of acute alcoholic hepatitis</h2><p class="" id=d56525e638>The pharmacotherapy for AH has changed little since the introduction of corticosteroids in the early 1970s<sup><a href="#ref-55">55</a></sup>, and although an early clinical trial demonstrated that pentoxifylline decreased short-term mortality by reducing rates of renal failure<sup><a href="#ref-56">56</a></sup>, the recently reported STOPAH (steroids or pentoxifylline for alcoholic hepatitis) study has raised concerns regarding the efficacy of both treatments<sup><a href="#ref-57">57</a></sup>. Over 1,100 patients were enrolled from hospitals throughout Britain and randomly assigned into a 22 factorial designed clinical trial to study the benefit of corticosteroids and pentoxifylline. Corticosteroids demonstrated a trend toward reduced 28-day mortality compared with placebo (14% versus 18%, <i>P</i> = 0.06), but no reduction was observed for 90-day mortality. Pentoxifylline provided no improvements in either short-term or long-term mortality. Importantly, mortality rates were significantly lower than those reported in other clinical trials of severe AH. As biopsy-proven AH was not used as an inclusion criterion, this raised concerns regarding whether a subset of patients had acute-on-chronic liver failure related to decompensated cirrhosis as opposed to AH. Two recent meta-analyses of randomized controlled trials reported that corticosteroids provided significant survival benefit at 28 days but not at 90 or 180 days<sup><a href="#ref-58">58</a>,<a href="#ref-59">59</a></sup>, although the last updated Cochrane meta-analysis continues to find no benefit. Given the short-term benefits of corticosteroids, their judicious use is still warranted in selected populations.<b></b></p><p class="" id=d56525e665>There is increasing interest in novel treatments for severe AH (<a href="#T2">Table 2</a>). Ongoing trials are exploring the efficacy of antibiotic therapy, farsenoid X receptor (FXR) agonists (obeticholic acid), caspase inhibitors (emricasan), receptor tyrosine kinase inhibitors (selonsertib), IL-1R antagonists (anakinra), and IL-22 agonists. Of particular interest is the use granulocyte-colony stimulating factor (G-CSF). The rationale for G-CSF is based on (1) histologic studies demonstrating that increased hepatic neutrophil infiltration is associated with improved survival in AH<sup><a href="#ref-37">37</a></sup> and (2) pre-clinical observations that G-CSF mobilizes granulocytes to improve survival in acute-on-chronic liver failure<sup><a href="#ref-60">60</a></sup>. A few randomized pilot studies from India have shown increased survival and more rapid decline in MELD scores in both decompensated cirrhosis and AH<sup><a href="#ref-61">61</a><a href="#ref-65">65</a></sup>. Though promising, these results will require replication in other clinical centers.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Recent/ongoing clinical trials for treatment of alcoholic hepatitis.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d56525e697 class=n-a></a><thead><a name=d56525e699 class=n-a></a><tr><a name=d56525e701 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e703 class=n-a></a>Agent</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e706 class=n-a></a>Mechanism of<br class=br>action</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e711 class=n-a></a>Study design</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e714 class=n-a></a>Inclusion criteria</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e717 class=n-a></a>Primary<br class=br>endpoint</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e723 class=n-a></a>ClinicalTrials.gov identifier<br class=br>and status</th></tr></thead><tbody><a name=d56525e730 class=n-a></a><tr><a name=d56525e732 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e734 class=n-a></a>G-CSF</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e737 class=n-a></a>Hepatic neutrophil<br class=br>expansion, liver<br class=br>regeneration</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e744 class=n-a></a>Placebo-controlled<br class=br>RCT:<br class=br>+ CS in PR<br class=br>No CS in NR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e753 class=n-a></a>DF 32</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e756 class=n-a></a>NR: 2-month<br class=br>survival<br class=br><br class=br>PR: 6-month<br class=br>survival</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e767 class=n-a></a>NCT02442180, phase IV,<br class=br>enrolling</td></tr><tr><a name=d56525e773 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e775 class=n-a></a>OCA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e778 class=n-a></a>FXR agonist</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e781 class=n-a></a>Placebo-controlled<br class=br>RCT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e786 class=n-a></a>MELD 1120</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e789 class=n-a></a>MELD change<br class=br>after 6 weeks</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e795 class=n-a></a>NCT02039219, phase II,<br class=br>completed</td></tr><tr><a name=d56525e801 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e803 class=n-a></a>Amoxicillin/<br class=br>Clavulanic acid</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e808 class=n-a></a>Gut microbiome<br class=br>modulation, infection<br class=br>prevention</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e815 class=n-a></a>Placebo-controlled<br class=br>RCT with CS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e820 class=n-a></a>MELD 21</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e823 class=n-a></a>2-month<br class=br>survival</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e829 class=n-a></a>NCT02281929, phase III,<br class=br>active, not enrolling</td></tr><tr><a name=d56525e835 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e837 class=n-a></a>Emricasan</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e840 class=n-a></a>Caspase inhibitor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e843 class=n-a></a>Placebo-controlled<br class=br>RCT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e848 class=n-a></a>MELD 2035 or<br class=br>MELD &gt;35 plus<br class=br>SOFA &lt;10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e855 class=n-a></a>28-day<br class=br>survival</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e861 class=n-a></a>NCT01912404, phase II,<br class=br>terminated</td></tr><tr><a name=d56525e867 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e869 class=n-a></a>Selonsertib</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e872 class=n-a></a>ASK-1 inhibitor,<br class=br>MAPK inhibitor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e877 class=n-a></a>Placebo-controlled<br class=br>RCT with CS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e882 class=n-a></a>DF 32</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e885 class=n-a></a>Safety at 28<br class=br>days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e891 class=n-a></a>NCT02854631, phase II,<br class=br>completed</td></tr><tr><a name=d56525e898 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e900 class=n-a></a>Anakinra</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e903 class=n-a></a>IL-1R antagonist</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e906 class=n-a></a>RCT of Anakinra +<br class=br>Zinc + PTX versus<br class=br>CS alone</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e913 class=n-a></a>MELD 20 and DF<br class=br>32</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e918 class=n-a></a>6-month<br class=br>survival</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e924 class=n-a></a>NCT01809132, phase II,<br class=br>completed</td></tr><tr><a name=d56525e930 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e932 class=n-a></a>IL-22</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e935 class=n-a></a>Hepatic regeneration</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e938 class=n-a></a>Open-label</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e941 class=n-a></a>MELD 1128</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e944 class=n-a></a>Safety at 42<br class=br>days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e950 class=n-a></a>NCT unavailable, phase I<br class=br>completed</td></tr><tr><a name=d56525e956 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e958 class=n-a></a>FMT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e961 class=n-a></a>Alleviates gut<br class=br>dysbiosis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e966 class=n-a></a>Open-label</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e969 class=n-a></a>DF 32 and low-<br class=br>grade HE</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e974 class=n-a></a>3-month<br class=br>survival</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e980 class=n-a></a>NCT03827772, phase II,<br class=br>enrolling</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=TFN2 class=n-a></a><p id=d56525e992> ASK-1, apoptosis signal-regulating kinase-1; CS, corticosteroids; DF, discriminant function; FMT, fecal microbiota transplantation; FXR, farsenoid X receptor; G-CSF, granulocyte colony-stimulating factor; HE, hepatic encephalopathy; IL-1R, interleukin-1 receptor; IL-22, interleukin-22; MELD, Model for End-Stage Liver Disease; NR, non-responder; OCA, obeticholic acid; PR, partial responder; PTX, pentoxifylline; RCT, randomized controlled trial; SOFA, sequential organ failure assessment.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d56525e1002>Supportive measures</h2><div class=section><a name=d56525e1005 class=n-a></a><h3 class=section-title>Alcohol abstinence</h3><p class="" id=d56525e1010>Although corticosteroids marginally improve short-term mortality, only alcohol abstinence has been shown to increase 6-month survival<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. Most patients with AH meet criteria for an alcohol use disorder (AUD), characterized by ongoing alcohol consumption despite experiencing adverse consequences of drinking<sup><a href="#ref-68">68</a></sup>. Therefore, use of screening tools to diagnose AUDs in patients with AH is critical to guide referral to optimal treatment pathways. One recent meta-analysis of the AUD Identification Test-Consumption (AUDIT-C)<sup><a href="#ref-69">69</a></sup> (<a target=xrefwindow href="https://www.drugabuse.gov/sites/default/files/files/AUDIT.pdf" id=d56525e1027>https://www.drugabuse.gov/sites/default/files/files/AUDIT.pdf</a>) demonstrated feasibility and efficacy of this instrument for identification of AUDs; furthermore, counseling interventions in those patients testing positive led to reductions in harmful alcohol consumption<sup><a href="#ref-70">70</a></sup>.</p><p class="" id=d56525e1035>In addition to addiction counseling, pharmacotherapy for AUD is now available (<a href="#T3">Table 3</a>). Although disulfram and naltrexone have US Food and Drug Administration approval for treatment of AUD, both drugs exhibit significant hepatotoxicity limiting their use in advanced liver disease. Baclofen has been studied extensively for AUD treatment in patients. Given the limited hepatic metabolism of baclofen, there is a theoretically lower risk of hepatotoxocity. Results of baclofen treatment trials, however, are mixed<sup><a href="#ref-71">71</a></sup>. Whereas one meta-analysis of 14 studies demonstrated no superiority of baclofen over placebo<sup><a href="#ref-72">72</a></sup>, two other meta-analyses demonstrated increased rates of abstinence and increased time to first relapse with baclofen<sup><a href="#ref-73">73</a>,<a href="#ref-74">74</a></sup>. Other drugs with low reported risk of hepatic injury include acamprosate, gabapentin, topiramate, and varenicline. However, of these agents, only acamprosate is approved for treatment of AUD. A recent meta-analysis demonstrated reduced rates of alcohol relapse for acamprosate (number needed-to-treat of 12; 27 trials)<sup><a href="#ref-75">75</a></sup>. Although further trials are needed to assess efficacy specifically in alcoholic liver disease, acamprosate represents an alternative therapeutic option in survivors of an episode of severe AH.</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Pharmacotherapy for alcohol use disorder.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d56525e1071 class=n-a></a><thead><a name=d56525e1073 class=n-a></a><tr><a name=d56525e1075 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e1077 class=n-a></a>Drug</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e1080 class=n-a></a>Mechanism of action</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e1083 class=n-a></a>Dose</th><th align=left colspan=1 rowspan=1 valign=top><a name=d56525e1086 class=n-a></a>Hepatic metabolism and risk of toxicity</th></tr></thead><tbody><a name=d56525e1091 class=n-a></a><tr><a name=d56525e1093 class=n-a></a><td align=left colspan=4 rowspan=1 valign=top><a name=d56525e1095 class=n-a></a>FDA-approved</td></tr><tr><a name=d56525e1099 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1101 class=n-a></a>Acamprosate</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1104 class=n-a></a>NDMA agonist</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1107 class=n-a></a>666 mg orally three times daily<br class=br>(333 mg with renal dysfunction)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1112 class=n-a></a>No hepatic metabolism, adjust dose in kidney<br class=br>injury</td></tr><tr><a name=d56525e1118 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1120 class=n-a></a>Disulfram</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1123 class=n-a></a>Acetaldehyde<br class=br>dehydrogenase inhibitor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1128 class=n-a></a>250500 mg orally daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1131 class=n-a></a>No hepatic metabolism, associated with drug-<br class=br>induced liver injury</td></tr><tr><a name=d56525e1137 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1139 class=n-a></a>Naltrexone</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1142 class=n-a></a>Mu-opiate receptor<br class=br>antagonist</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1147 class=n-a></a>50 mg orally daily or 380 mg<br class=br>intra-muscularly monthly</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1152 class=n-a></a>Hepatocellular injury described</td></tr><tr><a name=d56525e1156 class=n-a></a><td align=left colspan=4 rowspan=1 valign=top><a name=d56525e1158 class=n-a></a>Not FDA-approved</td></tr><tr><a name=d56525e1163 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1165 class=n-a></a>Baclofen</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1168 class=n-a></a>GABA-B receptor agonist</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1171 class=n-a></a>Up to 80 mg daily orally in<br class=br>divided doses</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1176 class=n-a></a>Minimal hepatic metabolism; formally studied in<br class=br>cirrhosis</td></tr><tr><a name=d56525e1182 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1184 class=n-a></a>Gabapentin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1187 class=n-a></a>GABA modulator</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1190 class=n-a></a>9001800 mg daily in divided<br class=br>doses</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1195 class=n-a></a>No hepatic metabolism; sedation risk in cirrhotic<br class=br>patients with hepatic encephalopathy</td></tr><tr><a name=d56525e1201 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1203 class=n-a></a>Topiramate</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1206 class=n-a></a>Anticonvulsant</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1209 class=n-a></a>300 mg orally daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1212 class=n-a></a>Partial hepatic metabolism via glucoronidation</td></tr><tr><a name=d56525e1216 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1218 class=n-a></a>Varenicline</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1221 class=n-a></a>Nicotinic receptor agonist</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1224 class=n-a></a>2 mg orally daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d56525e1227 class=n-a></a>Minimal hepatic metabolism</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=TFN3 class=n-a></a><p id=d56525e1237> FDA, US Food and Drug Administration; GABA, gamma aminobutyric acid; NMDA, <i>N</i>-methyl-<span style="font-variant: small-caps">d</span>-aspartate.</p></div></div></div></div><div class=section><a name=d56525e1250 class=n-a></a><h3 class=section-title>Identification and treatment of infections</h3><p class="" id=d56525e1255>Infections are a common complication of AH and contribute to increased mortality in AH<sup><a href="#ref-76">76</a></sup>. In the STOPAH trial, infections were responsible for 24% of all deaths<sup><a href="#ref-57">57</a></sup>. Patients with severe AH are at particularly increased risk for infection for a number of reasons. First, immune function of circulating innate immune cells is impaired, as multiple studies have identified decreased phagocytic activity, oxidative burst, and proliferation in severe AH<sup><a href="#ref-77">77</a>,<a href="#ref-78">78</a></sup>. Second, immunosuppression with corticosteroids impacts infection risk, as shown in a subanalysis of the STOPAH trial where circulating bacterial DNA detected at enrollment was associated with development of early infections (within 7 days of commencing treatment) only among patients who received prednisolone<sup><a href="#ref-79">79</a></sup>. The source and type of infection also change during the disease course. In an early study of AH, spontaneous bacterial peritonitis and spontaneous bacteremia were leading infections at initial presentation whereas respiratory infections were the most common infections after exposure to corticosteroids<sup><a href="#ref-80">80</a></sup>. Although Gram-negative bacteria are the leading organisms identified in AH, recent studies have reported invasive fungal infections. For example, in a series of 120 consecutive AH patients admitted to an intensive care unit, 10% developed invasive fungal infections, including candidemia and invasive aspergillosis infections; all were exposed to corticosteroids<sup><a href="#ref-81">81</a></sup>.</p><p class="" id=d56525e1286>Finally, early diagnosis of infection in AH is particularly challenging in patients with systemic inflammatory response syndrome (SIRS), which is diagnosed when two or more of the following criteria are met: (a) white blood cell count of more than 12,000/mL or less than 4,000/mL or more than 10% bands, (b) temperature of more than 38C or less than 36C, (c) heart rate of more than 90 beats/minute, (d) respiratory rate of more than 20/minute. In one study, SIRS was present in 20% of patients at admission and was associated with multiple organ failure and short-term death<sup><a href="#ref-82">82</a></sup> independent of the presence of infection. Owing to the high rate of negative bacterial cultures in AH patients with SIRS, there is growing interest in the development of novel infection biomarkers in AH. Small studies have demonstrated efficacy of bacterial DNA and LPS<sup><a href="#ref-79">79</a>,<a href="#ref-82">82</a></sup> to screen for infections, but further research is needed to validate these findings. As up to 26% of patients with AH initially present with infection<sup><a href="#ref-80">80</a></sup>, baseline screening for infection (blood cultures, urine cultures, chest radiography, and ascitic fluid analysis) is routinely performed; furthermore, a clinical trial studying the use of amoxicillin/clavulanic acid with prednisolone in patients with severe AH was nearing completion by December 2019 (ClinicalTrials.gov identifier: NCT02281929).</p></div><div class=section><a name=d56525e1305 class=n-a></a><h3 class=section-title>Evaluation of nutritional status and nutritional support</h3><p class="" id=d56525e1310>Malnutritionin particular, protein-calorie malnutritionis a well-recognized complication of AH<sup><a href="#ref-83">83</a>,<a href="#ref-84">84</a></sup>. With the rising epidemic of obesity in Western nations, a subjective physical assessment by treating clinicians may incorrectly classify nutritional status in severe AH. Although a recent randomized clinical trial failed to demonstrate intense enteral nutrition via nasogastric tube superior to oral nutrition in patients with AH treated with corticosteroids, a subgroup analysis showed that patients receiving less than 21.5 kcal/kg per day had lower 6-month survival than patients meeting this threshold, and reduced survival was associated with decreased protein and lipid content in the diet<sup><a href="#ref-85">85</a></sup>. In addition, multiple macro- and micro-nutrient deficiencies have been described in AH. In particular, zinc deficiency is associated with increased intestinal permeability<sup><a href="#ref-86">86</a></sup>, and a clinical trial incorporating zinc supplementation (ClinicalTrials.gov identifier: NCT01809132) was completed in December 2018.</p><p class="" id=d56525e1328>Recently, there has been renewed interest in the use of objective measures of nutritional status and physical function for outcome prediction in cirrhosis. In patients with decompensated cirrhosis, 6-minute walk test, cross-sectional abdominal muscle area, and gait speed are strongly associated with mortality, LT waitlist dropout, and increased hospital-related expenditures<sup><a href="#ref-87">87</a><a href="#ref-89">89</a></sup>. Furthermore, a liver frailty index composed of dominant grip strength, chair stands, and balance was recently shown to predict survival in decompensated cirrhosis<sup><a href="#ref-90">90</a></sup>. Although these tools have yet to be incorporated into prognostic models in AH, they may hold potential, in particular, for predicting long-term outcomes in short-term survivors of an episode of AH.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d56525e1346>Early liver transplantation for alcoholic hepatitis</h2><p class="" id=d56525e1349>Patients with AH who fail corticosteroids have poor long-term survival, and some studies reported up to 75% 6-month mortality<sup><a href="#ref-44">44</a></sup>. Therefore, LT has emerged as a potential curative therapy for AH. Historically, transplantation for alcoholic liver disease has required demonstration of abstinence for at least 6 months. The genesis of the 6-month rule, however, was to permit recovery from an episode of acute-on-chronic liver failure after prolonged abstinence, but by the late 1990s, most US LT programs and insurance carriers required a 6-month abstinence period prior to approving LT listing. Multiple studies have examined the utility of the pre-transplant sobriety for predicting post-transplant relapse, but results have been conflicting. In one landmark analysis of LTs performed for alcoholic liver disease, steatohepatitis on explant pathology was used as a surrogate marker of recent alcohol consumption; interestingly, there were no differences in patient survival, graft survival, or alcohol relapse rates between subjects with and without steatohepatitis<sup><a href="#ref-91">91</a></sup>. Also, a systematic review of 22 studies reported that duration of pre-transplant abstinence was a poor predictor of post-transplant relapse<sup><a href="#ref-92">92</a></sup>, although some reports have identified duration of pre-transplant sobriety as a predictor of post-transplant drinking<sup><a href="#ref-93">93</a><a href="#ref-95">95</a></sup>. Interestingly, the United Network for Organ Sharing has never formally recommended a 6-month rule for transplant candidacy.</p><p class="" id=d56525e1371>In a prospective, multi-center European trial, early LT for steroid non-responders afforded a marked survival benefit when compared with historical matched controls (6-month survival of 77% versus 23%, respectively; <i>P</i> &lt;0.001)<sup><a href="#ref-96">96</a></sup>. Importantly, these transplants accounted for only 2.9% of all transplants performed at participating centers over the same period, thus allaying concerns regarding reduced donor availability for other liver diseases. Since this report, a number of single-center studies have reported similar survival benefit<sup><a href="#ref-97">97</a>,<a href="#ref-98">98</a></sup>. In particular, a recent US series of 147 LT recipients across 12 centers demonstrated a 3-year survival of 84%, and survival was 100% in patients who maintained sobriety after LT<sup><a href="#ref-99">99</a></sup>. Outcome modeling using data from the two seminal trials showed that early transplantation improves survival when compared with the 6-month probationregardless of estimated post-transplant alcohol recidivismand the highest survival advantage was among patients with a Lille score of 0.5 to 0.82 and a MELD score of at least 32<sup><a href="#ref-100">100</a></sup>.</p><p class="" id=d56525e1396>Reported psychosocial selection criteria across transplant centers are variable but appear to adhere to the following principles: (1) adequate psychosocial support, (2) a first episode of hepatic decompensation related to alcohol use, (3) absence of other substance use disorders, (4) absence of untreated psychiatric disease, and (5) acknowledgment of an AUD and willingness to participate in alcohol rehabilitation to maintain abstinence after LT. More recently, a model for alcohol relapse after LT identified prior alcohol-related legal issues and multiple failed alcohol rehabilitation attempts as additional risk factors<sup><a href="#ref-99">99</a>,<a href="#ref-101">101</a></sup>. Future studies are needed to optimize uniform selection criteria to (1) maximize long-term abstinence in LT recipients with severe AH and (2) ensure equity and fairness in the care of patients with severe AH.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d56525e1409>Conclusions</h2><p class="" id=d56525e1412>AH is a life-threatening form of acute-on-chronic liver failure in patients with chronic heavy alcohol use. Given temporal trends in alcohol consumption patterns worldwide, the incidence of AH, especially in young adults, is expected to rise in the next decade. Despite high rates of short-term mortality in severe AH, the treatment of AH and accompanying AUD has remained largely unchanged since the 1970s. A marked increase in the number of diagnostic and therapeutic trials in the last decade, however, reflects a growing interest in this devastating disease. LT is a life-saving therapeutic option for AH and is to be encouraged particularly in patients with a favorable profile and low risk for alcohol recidivism. Future studies should aim to improve post-transplant addiction support in order to maximize transplant benefits.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d56525e1419 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d57189>References</h2><div class="section ref-list"><a name=d56525e1419 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d56525e1426 class=n-a></a>Singal AK, Kamath PS, Gores GJ, <i> et al.</i>: Alcoholic hepatitis: current challenges and future directions. <i>Clin Gastroenterol Hepatol.</i> 2014; <b>12</b>(4): 55564; quiz e312. <a target=xrefwindow id=d56525e1437 href="http://www.ncbi.nlm.nih.gov/pubmed/23811249">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1440 href="https://doi.org/10.1016/j.cgh.2013.06.013">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1444 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3883924">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d56525e1453 class=n-a></a>Crabb DW, Bataller R, Chalasani NP, <i> et al.</i>: Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. <i>Gastroenterology.</i> 2016; <b>150</b>(4): 78590. <a target=xrefwindow id=d56525e1464 href="http://www.ncbi.nlm.nih.gov/pubmed/26921783">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1467 href="https://doi.org/10.1053/j.gastro.2016.02.042">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1471 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5287362">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d56525e1480 class=n-a></a>Xuan Z, Nelson TF, Heeren T, <i> et al.</i>: Tax policy, adult binge drinking, and youth alcohol consumption in the United States. <i>Alcohol Clin Exp Res.</i> 2013; <b>37</b>(10): 17139. <a target=xrefwindow id=d56525e1491 href="http://www.ncbi.nlm.nih.gov/pubmed/23711219">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1494 href="https://doi.org/10.1111/acer.12152">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1498 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3795905">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d56525e1507 class=n-a></a>Yrk BK: Legalization of Sunday alcohol sales and alcohol consumption in the United States. <i>Addiction.</i> 2014; <b>109</b>(1): 5561. <a target=xrefwindow id=d56525e1515 href="http://www.ncbi.nlm.nih.gov/pubmed/24103041">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1518 href="https://doi.org/10.1111/add.12358">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1521 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3947002">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d56525e1530 class=n-a></a>Siegel M, DeJong W, Naimi TS, <i> et al.</i>: Alcohol brand preferences of underage youth: results from a pilot survey among a national sample. <i>Subst Abus.</i> 2011; <b>32</b>(4): 191201. <a target=xrefwindow id=d56525e1541 href="http://www.ncbi.nlm.nih.gov/pubmed/22014249">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1544 href="https://doi.org/10.1080/08897077.2011.601250">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1548 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3202336">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d56525e1558 class=n-a></a>Siegel MB, Naimi TS, Cremeens JL, <i> et al.</i>: Alcoholic beverage preferences and associated drinking patterns and risk behaviors among high school youth. <i>Am J Prev Med.</i> 2011; <b>40</b>(4): 41926. <a target=xrefwindow id=d56525e1569 href="http://www.ncbi.nlm.nih.gov/pubmed/21406275">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1572 href="https://doi.org/10.1016/j.amepre.2010.12.011">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d56525e1581 class=n-a></a>Bor J, Basu S, Coutts A, <i> et al.</i>: Alcohol use during the great recession of 20082009. <i>Alcohol Alcohol.</i> 2013; <b>48</b>(3): 3438. <a target=xrefwindow id=d56525e1592 href="http://www.ncbi.nlm.nih.gov/pubmed/23360873">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1595 href="https://doi.org/10.1093/alcalc/agt002">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733663294"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e1604 class=n-a></a>Tapper EB, Parikh ND: Mortality due to cirrhosis and liver cancer in the United States, 19992016: observational study. <i>BMJ.</i> 2018; <b>362</b>: k2817. <a target=xrefwindow id=d56525e1612 href="http://www.ncbi.nlm.nih.gov/pubmed/30021785">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1615 href="https://doi.org/10.1136/bmj.k2817">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1618 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6050518">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733663294">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d56525e1631 class=n-a></a>Sandahl TD, Jepsen P, Thomsen KL, <i> et al.</i>: Incidence and mortality of alcoholic hepatitis in Denmark 19992008: a nationwide population based cohort study. <i>J Hepatol.</i> 2011; <b>54</b>(4): 7604. <a target=xrefwindow id=d56525e1642 href="http://www.ncbi.nlm.nih.gov/pubmed/21126790">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1645 href="https://doi.org/10.1016/j.jhep.2010.07.016">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d56525e1654 class=n-a></a>Jinjuvadia R, Liangpunsakul S, ; Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium: Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States. <i>J Clin Gastroenterol.</i> 2015; <b>49</b>(6): 50611. <a target=xrefwindow id=d56525e1662 href="http://www.ncbi.nlm.nih.gov/pubmed/25198164">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1665 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4276725">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d56525e1674 class=n-a></a>Barritt AS, Jiang Y, Schmidt M, <i> et al.</i>: Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis. <i>Dig Dis Sci.</i> 2019; <b>64</b>(6): 14609. <a target=xrefwindow id=d56525e1685 href="http://www.ncbi.nlm.nih.gov/pubmed/30673984">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1688 href="https://doi.org/10.1007/s10620-019-5471-7">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d56525e1698 class=n-a></a>Nagy LE: The Role of Innate Immunity in Alcoholic Liver Disease. <i>Alcohol Res.</i> 2015; <b>37</b>(2): 23750. <a target=xrefwindow id=d56525e1706 href="http://www.ncbi.nlm.nih.gov/pubmed/26695748">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1709 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4590620">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d56525e1718 class=n-a></a>Petrasek J, Csak T, Szabo G: Toll-like receptors in liver disease. <i>Adv Clin Chem.</i> 2013; <b>59</b>: 155201. <a target=xrefwindow id=d56525e1726 href="http://www.ncbi.nlm.nih.gov/pubmed/23461136">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1729 href="https://doi.org/10.1016/b978-0-12-405211-6.00006-1">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d56525e1738 class=n-a></a>Gao B, Bataller R: Alcoholic liver disease: pathogenesis and new therapeutic targets. <i>Gastroenterology.</i> 2011; <b>141</b>(5): 157285. <a target=xrefwindow id=d56525e1746 href="http://www.ncbi.nlm.nih.gov/pubmed/21920463">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1749 href="https://doi.org/10.1053/j.gastro.2011.09.002">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1752 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3214974">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d56525e1761 class=n-a></a>Yin H, Hu M, Zhang R, <i> et al.</i>: MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1. <i>J Biol Chem.</i> 2012; <b>287</b>(13): 981726. <a target=xrefwindow id=d56525e1772 href="http://www.ncbi.nlm.nih.gov/pubmed/22308024">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1775 href="https://doi.org/10.1074/jbc.M111.333534">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1779 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3323059">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/719991503"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d56525e1788 class=n-a></a>Leclercq S, Matamoros S, Cani PD, <i> et al.</i>: Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(42): E4485E4493. <a target=xrefwindow id=d56525e1799 href="http://www.ncbi.nlm.nih.gov/pubmed/25288760">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1802 href="https://doi.org/10.1073/pnas.1415174111">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1806 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4210345">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/719991503">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d56525e1821 class=n-a></a>Parlesak A, Schfer C, Schtz T, <i> et al.</i>: Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. <i>J Hepatol.</i> 2000; <b>32</b>(5): 7427. <a target=xrefwindow id=d56525e1832 href="http://www.ncbi.nlm.nih.gov/pubmed/10845660">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1835 href="https://doi.org/10.1016/S0168-8278(00)80242-1">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d56525e1845 class=n-a></a>Dominguez M, Miquel R, Colmenero J, <i> et al.</i>: Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. <i>Gastroenterology.</i> 2009; <b>136</b>(5): 163950. <a target=xrefwindow id=d56525e1856 href="http://www.ncbi.nlm.nih.gov/pubmed/19208360">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1859 href="https://doi.org/10.1053/j.gastro.2009.01.056">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d56525e1868 class=n-a></a>Dubuquoy L, Louvet A, Lassailly G, <i> et al.</i>: Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. <i>Gut.</i> 2015; <b>64</b>(12): 194960. <a target=xrefwindow id=d56525e1879 href="http://www.ncbi.nlm.nih.gov/pubmed/25731872">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1882 href="https://doi.org/10.1136/gutjnl-2014-308410">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1886 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4558407">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725433461"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d56525e1895 class=n-a></a>Lanthier N, Rubbia-Brandt L, Lin-Marq N, <i> et al.</i>: Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis. <i>J Hepatol.</i> 2015; <b>63</b>(3): 60921. <a target=xrefwindow id=d56525e1906 href="http://www.ncbi.nlm.nih.gov/pubmed/25872168">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1909 href="https://doi.org/10.1016/j.jhep.2015.04.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725433461">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d56525e1927 class=n-a></a>Sancho-Bru P, Altamirano J, Rodrigo-Torres D, <i> et al.</i>: Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. <i>Hepatology.</i> 2012; <b>55</b>(6): 193141. <a target=xrefwindow id=d56525e1938 href="http://www.ncbi.nlm.nih.gov/pubmed/22278680">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1941 href="https://doi.org/10.1002/hep.25614">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d56525e1950 class=n-a></a>Argemi J, Latasa MU, Atkinson SR, <i> et al.</i>: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. <i>Nat Commun.</i> 2019; <b>10</b>(1): 3126. <a target=xrefwindow id=d56525e1961 href="http://www.ncbi.nlm.nih.gov/pubmed/31311938">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1964 href="https://doi.org/10.1038/s41467-019-11004-3">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1968 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6635373">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732876074"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d56525e1977 class=n-a></a>Abul-Husn NS, Cheng X, Li AH, <i> et al.</i>: A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease. <i>N Engl J Med.</i> 2018; <b>378</b>(12): 1096106. <a target=xrefwindow id=d56525e1988 href="http://www.ncbi.nlm.nih.gov/pubmed/29562163">PubMed Abstract </a> | <a target=xrefwindow id=d56525e1991 href="https://doi.org/10.1056/NEJMoa1712191">Publisher Full Text </a> | <a target=xrefwindow id=d56525e1995 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6668033">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732876074">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2168956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d56525e2014 class=n-a></a>Tian C, Stokowski RP, Kershenobich D, <i> et al.</i>: Variant in PNPLA3 is associated with alcoholic liver disease. <i>Nat Genet.</i> 2010; <b>42</b>(1): 213. <a target=xrefwindow id=d56525e2025 href="http://www.ncbi.nlm.nih.gov/pubmed/19946271">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2028 href="https://doi.org/10.1038/ng.488">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2168956">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d56525e2046 class=n-a></a>Buch S, Stickel F, Trpo E, <i> et al.</i>: A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. <i>Nat Genet.</i> 2015; <b>47</b>(12): 14438. <a target=xrefwindow id=d56525e2057 href="http://www.ncbi.nlm.nih.gov/pubmed/26482880">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2060 href="https://doi.org/10.1038/ng.3417">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d56525e2069 class=n-a></a>Segado Soriano A, Santiago Dorrego C, Baares Caizares R, <i> et al.</i>: [Genetic susceptibility to the development of acute alcoholic hepatitis: role of genetic mutations in dehydrogenase alcohol, aldehyde dehydrogenase and cytochrome P450 2E1]. <i>Rev Clin Esp.</i> 2005; <b>205</b>(11): 52832. <a target=xrefwindow id=d56525e2080 href="http://www.ncbi.nlm.nih.gov/pubmed/16324524">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2083 href="https://doi.org/10.1016/s0014-2565(05)72632-1">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732141901"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d56525e2092 class=n-a></a>Trpo E, Goossens N, Fujiwara N, <i> et al.</i>: Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis. <i>Gastroenterology.</i> 2018; <b>154</b>(4): 96575. <a target=xrefwindow id=d56525e2103 href="http://www.ncbi.nlm.nih.gov/pubmed/29158192">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2106 href="https://doi.org/10.1053/j.gastro.2017.10.048">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2110 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5847453">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732141901">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d56525e2128 class=n-a></a>Bajaj JS: Alcohol, liver disease and the gut microbiota. <i>Nat Rev Gastroenterol Hepatol.</i> 2019; <b>16</b>(4): 23546. <a target=xrefwindow id=d56525e2136 href="http://www.ncbi.nlm.nih.gov/pubmed/30643227">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2139 href="https://doi.org/10.1038/s41575-018-0099-1">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d56525e2148 class=n-a></a>Llopis M, Cassard AM, Wrzosek L, <i> et al.</i>: Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. <i>Gut.</i> 2016; <b>65</b>(5): 8309. <a target=xrefwindow id=d56525e2159 href="http://www.ncbi.nlm.nih.gov/pubmed/26642859">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2162 href="https://doi.org/10.1136/gutjnl-2015-310585">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation> <a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727458445"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a> <a name=d56525e2172 class=n-a></a>Lowe PP, Gyongyosi B, Satishchandran A, <i> et al.</i>: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice. <i>PLoS One.</i> 2017; <b>12</b>(3): e0174544. <a target=xrefwindow id=d56525e2183 href="http://www.ncbi.nlm.nih.gov/pubmed/28350851">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2186 href="https://doi.org/10.1371/journal.pone.0174544">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2190 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5370121">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727458445">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d56525e2208 class=n-a></a>Lang S, Duan Y, Liu J, <i> et al.</i>: Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis. <i>Hepatology.</i> 2019. <a target=xrefwindow id=d56525e2216 href="http://www.ncbi.nlm.nih.gov/pubmed/31228214">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2219 href="https://doi.org/10.1002/hep.30832">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2222 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6925657">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734042453"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2231 class=n-a></a>Konturek PC, Harsch IA, Konturek K, <i> et al.</i>: GutLiver Axis: How Do Gut Bacteria Influence the Liver? <i>Med Sci (Basel).</i> 2018; <b>6</b>(3): pii: E79. <a target=xrefwindow id=d56525e2242 href="http://www.ncbi.nlm.nih.gov/pubmed/30227645">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2245 href="https://doi.org/10.3390/medsci6030079">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2249 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6165386">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734042453">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d56525e2262 class=n-a></a>Jimenez C, Ventura M, Sala M, <i> et al.</i>: Use of rifaximin in alcoholic hepatitis: Pilot study. <i>J Hepatol.</i> 2018; <b>68</b>: S816. <a target=xrefwindow id=d56525e2273 href="https://doi.org/10.1016/S0168-8278(18)31905-6">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726945786"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2282 class=n-a></a>Philips CA, Pande A, Shasthry SM, <i> et al.</i>: Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study. <i>Clin Gastroenterol Hepatol.</i> 2017; <b>15</b>(4): 6002. <a target=xrefwindow id=d56525e2293 href="http://www.ncbi.nlm.nih.gov/pubmed/27816755">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2296 href="https://doi.org/10.1016/j.cgh.2016.10.029">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726945786">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d56525e2309 class=n-a></a>European Association for the Study of Liver: EASL clinical practical guidelines: management of alcoholic liver disease. <i>J Hepatol.</i> 2012; <b>57</b>(2): 399420. <a target=xrefwindow id=d56525e2317 href="http://www.ncbi.nlm.nih.gov/pubmed/22633836">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2320 href="https://doi.org/10.1016/j.jhep.2012.04.004">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d56525e2330 class=n-a></a>Lucey MR, Mathurin P, Morgan TR: Alcoholic hepatitis. <i>N Engl J Med.</i> 2009; <b>360</b>(26): 275869. <a target=xrefwindow id=d56525e2338 href="http://www.ncbi.nlm.nih.gov/pubmed/19553649">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2341 href="https://doi.org/10.1056/NEJMra0805786">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d56525e2350 class=n-a></a>Altamirano J, Miquel R, Katoonizadeh A, <i> et al.</i>: A histologic scoring system for prognosis of patients with alcoholic hepatitis. <i>Gastroenterology.</i> 2014; <b>146</b>(5): 12311239.e6. <a target=xrefwindow id=d56525e2361 href="http://www.ncbi.nlm.nih.gov/pubmed/24440674">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2364 href="https://doi.org/10.1053/j.gastro.2014.01.018">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2368 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3992184">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d56525e2377 class=n-a></a>Maddrey WC, Boitnott JK, Bedine MS, <i> et al.</i>: Corticosteroid therapy of alcoholic hepatitis. <i>Gastroenterology.</i> 1978; <b>75</b>(2): 1939. <a target=xrefwindow id=d56525e2388 href="http://www.ncbi.nlm.nih.gov/pubmed/352788">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2391 href="https://doi.org/10.1016/0016-5085(78)90401-8">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d56525e2400 class=n-a></a>Altamirano J, Fagundes C, Dominguez M, <i> et al.</i>: Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. <i>Clin Gastroenterol Hepatol.</i> 2012; <b>10</b>(1): 6571.e3. <a target=xrefwindow id=d56525e2411 href="http://www.ncbi.nlm.nih.gov/pubmed/21946124">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2414 href="https://doi.org/10.1016/j.cgh.2011.09.011">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d56525e2423 class=n-a></a>Dunn W, Jamil LH, Brown LS, <i> et al.</i>: MELD accurately predicts mortality in patients with alcoholic hepatitis. <i>Hepatology.</i> 2005; <b>41</b>(2): 3538. <a target=xrefwindow id=d56525e2434 href="http://www.ncbi.nlm.nih.gov/pubmed/15660383">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2437 href="https://doi.org/10.1002/hep.20503">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d56525e2446 class=n-a></a>Dominguez M, Rincn D, Abraldes JG, <i> et al.</i>: A new scoring system for prognostic stratification of patients with alcoholic hepatitis. <i>Am J Gastroenterol.</i> 2008; <b>103</b>(11): 274756. <a target=xrefwindow id=d56525e2457 href="http://www.ncbi.nlm.nih.gov/pubmed/18721242">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2460 href="https://doi.org/10.1111/j.1572-0241.2008.02104.x">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d56525e2470 class=n-a></a>Forrest EH, Evans CD, Stewart S, <i> et al.</i>: Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. <i>Gut.</i> 2005; <b>54</b>(8): 11749. <a target=xrefwindow id=d56525e2481 href="http://www.ncbi.nlm.nih.gov/pubmed/16009691">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2484 href="https://doi.org/10.1136/gut.2004.050781">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2488 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1774903">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d56525e2497 class=n-a></a>Forrest EH, Morris AJ, Stewart S, <i> et al.</i>: The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. <i>Gut.</i> 2007; <b>56</b>(12): 17436. <a target=xrefwindow id=d56525e2508 href="http://www.ncbi.nlm.nih.gov/pubmed/17627961">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2511 href="https://doi.org/10.1136/gut.2006.099226">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2515 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2095721">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1088007"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2524 class=n-a></a>Louvet A, Naveau S, Abdelnour M, <i> et al.</i>: The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. <i>Hepatology.</i> 2007; <b>45</b>(6): 134854. <a target=xrefwindow id=d56525e2535 href="http://www.ncbi.nlm.nih.gov/pubmed/17518367">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2538 href="https://doi.org/10.1002/hep.21607">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1088007">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d56525e2551 class=n-a></a>Garcia-Saenz-de-Sicilia M, Duvoor C, Altamirano J, <i> et al.</i>: A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis. <i>Am J Gastroenterol.</i> 2017; <b>112</b>(2): 30615. <a target=xrefwindow id=d56525e2562 href="http://www.ncbi.nlm.nih.gov/pubmed/27922027">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2565 href="https://doi.org/10.1038/ajg.2016.539">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d56525e2574 class=n-a></a>Louvet A, Labreuche J, Artru F, <i> et al.</i>: Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis. <i>Gastroenterology.</i> 2015; <b>149</b>(2): 398406.e8; quiz e167. <a target=xrefwindow id=d56525e2585 href="http://www.ncbi.nlm.nih.gov/pubmed/25935634">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2588 href="https://doi.org/10.1053/j.gastro.2015.04.044">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732181192"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2597 class=n-a></a>Forrest EH, Atkinson SR, Richardson P, <i> et al.</i>: Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis. <i>J Hepatol.</i> 2018; <b>68</b>(3): 5118. <a target=xrefwindow id=d56525e2608 href="http://www.ncbi.nlm.nih.gov/pubmed/29175535">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2611 href="https://doi.org/10.1016/j.jhep.2017.11.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732181192">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d56525e2625 class=n-a></a>Momen-Heravi F, Saha B, Kodys K, <i> et al.</i>: Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. <i>J Transl Med.</i> 2015; <b>13</b>: 261. <a target=xrefwindow id=d56525e2636 href="http://www.ncbi.nlm.nih.gov/pubmed/26264599">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2639 href="https://doi.org/10.1186/s12967-015-0623-9">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2643 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4533956">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d56525e2652 class=n-a></a>Szabo G, Bala S: Reply: To PMID 22684891. <i>Hepatology.</i> 2013; <b>57</b>(6): 2547. <a target=xrefwindow id=d56525e2660 href="http://www.ncbi.nlm.nih.gov/pubmed/23112144">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2663 href="https://doi.org/10.1002/hep.26111">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d56525e2672 class=n-a></a>Rachakonda V, Gabbert C, Raina A, <i> et al.</i>: Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines. <i>Alcohol Clin Exp Res.</i> 2014; <b>38</b>(11): 271221. <a target=xrefwindow id=d56525e2683 href="http://www.ncbi.nlm.nih.gov/pubmed/25421508">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2686 href="https://doi.org/10.1111/acer.12558">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2690 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4244659">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727879679"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2699 class=n-a></a>Woolbright BL, Bridges BW, Dunn W, <i> et al.</i>: Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18. <i>Gene Expr.</i> 2017; <b>17</b>(4): 30112. <a target=xrefwindow id=d56525e2710 href="http://www.ncbi.nlm.nih.gov/pubmed/28770701">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2713 href="https://doi.org/10.3727/105221617X15016197658871">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2717 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5885151">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727879679">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d56525e2730 class=n-a></a>Bissonnette J, Altamirano J, Devue C, <i> et al.</i>: A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis. <i>Hepatology.</i> 2017; <b>66</b>(2): 55563. <a target=xrefwindow id=d56525e2741 href="http://www.ncbi.nlm.nih.gov/pubmed/28120471">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2744 href="https://doi.org/10.1002/hep.29080">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734048880"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2753 class=n-a></a>Vatsalya V, Kong M, Gobejishvili L, <i> et al.</i>: Urinary acrolein metabolite levels in severe acute alcoholic hepatitis patients. <i>Am J Physiol Gastrointest Liver Physiol.</i> 2019; <b>316</b>(1): G115G122. <a target=xrefwindow id=d56525e2764 href="http://www.ncbi.nlm.nih.gov/pubmed/30234998">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2767 href="https://doi.org/10.1152/ajpgi.00209.2018">Publisher Full Text </a> | <a target=xrefwindow id=d56525e2771 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6383378">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734048880">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736212242"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2785 class=n-a></a>Forrest EH, Storey N, Sinha R, <i> et al.</i>: Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis. <i>Aliment Pharmacol Ther.</i> 2019; <b>50</b>(4): 44253. <a target=xrefwindow id=d56525e2796 href="http://www.ncbi.nlm.nih.gov/pubmed/31313853">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2799 href="https://doi.org/10.1111/apt.15335">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736212242">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d56525e2812 class=n-a></a>Porter HP, Simon FR, Pope CE, <i> et al.</i>: Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. <i>N Engl J Med.</i> 1971; <b>284</b>(24): 13505. <a target=xrefwindow id=d56525e2823 href="http://www.ncbi.nlm.nih.gov/pubmed/4930603">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2826 href="https://doi.org/10.1056/NEJM197106172842404">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d56525e2835 class=n-a></a>Akriviadis E, Botla R, Briggs W, <i> et al.</i>: Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. <i>Gastroenterology.</i> 2000; <b>119</b>(6): 163748. <a target=xrefwindow id=d56525e2846 href="http://www.ncbi.nlm.nih.gov/pubmed/11113085">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2849 href="https://doi.org/10.1053/gast.2000.20189">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725444905"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2858 class=n-a></a>Thursz MR, Richardson P, Allison M, <i> et al.</i>: Prednisolone or pentoxifylline for alcoholic hepatitis. <i>N Engl J Med.</i> 2015; <b>372</b>(17): 161928. <a target=xrefwindow id=d56525e2869 href="http://www.ncbi.nlm.nih.gov/pubmed/25901427">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2872 href="https://doi.org/10.1056/NEJMoa1412278">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725444905">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d56525e2885 class=n-a></a>Singh S, Murad MH, Chandar AK, <i> et al.</i>: Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. <i>Gastroenterology.</i> 2015; <b>149</b>(4): 958970.e12. <a target=xrefwindow id=d56525e2896 href="http://www.ncbi.nlm.nih.gov/pubmed/26091937">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2899 href="https://doi.org/10.1053/j.gastro.2015.06.006">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733200341"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2908 class=n-a></a>Louvet A, Thursz MR, Kim DJ, <i> et al.</i>: Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials. <i>Gastroenterology.</i> 2018; <b>155</b>(2): 458468.e8. <a target=xrefwindow id=d56525e2919 href="http://www.ncbi.nlm.nih.gov/pubmed/29738698">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2922 href="https://doi.org/10.1053/j.gastro.2018.05.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733200341">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d56525e2936 class=n-a></a>Garg V, Garg H, Khan A, <i> et al.</i>: Granulocyte colony-stimulating factor mobilizes CD34<sup>+</sup> cells and improves survival of patients with acute-on-chronic liver failure. <i>Gastroenterology.</i> 2012; <b>142</b>(3): 505512.e1. <a target=xrefwindow id=d56525e2950 href="http://www.ncbi.nlm.nih.gov/pubmed/22119930">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2954 href="https://doi.org/10.1053/j.gastro.2011.11.027">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725381884"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e2963 class=n-a></a>Kedarisetty CK, Anand L, Bhardwaj A, <i> et al.</i>: Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. <i>Gastroenterology.</i> 2015; <b>148</b>(7): 13621370.e7. <a target=xrefwindow id=d56525e2974 href="http://www.ncbi.nlm.nih.gov/pubmed/25749502">PubMed Abstract </a> | <a target=xrefwindow id=d56525e2977 href="https://doi.org/10.1053/j.gastro.2015.02.054">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725381884">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d56525e2990 class=n-a></a>Singh V, Sharma AK, Narasimhan RL, <i> et al.</i>: Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. <i>Am J Gastroenterol.</i> 2014; <b>109</b>(9): 141723. <a target=xrefwindow id=d56525e3001 href="http://www.ncbi.nlm.nih.gov/pubmed/24935272">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3004 href="https://doi.org/10.1038/ajg.2014.154">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d56525e3013 class=n-a></a>Spahr L, Lambert JF, Rubbia-Brandt L, <i> et al.</i>: Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. <i>Hepatology.</i> 2008; <b>48</b>(1): 2219. <a target=xrefwindow id=d56525e3024 href="http://www.ncbi.nlm.nih.gov/pubmed/18537187">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3027 href="https://doi.org/10.1002/hep.22317">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732596095"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3036 class=n-a></a>Singh V, Keisham A, Bhalla A, <i> et al.</i>: Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis. <i>Clin Gastroenterol Hepatol.</i> 2018; <b>16</b>(10): 16501656.e2. <a target=xrefwindow id=d56525e3047 href="http://www.ncbi.nlm.nih.gov/pubmed/29391265">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3050 href="https://doi.org/10.1016/j.cgh.2018.01.040">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732596095">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734895548"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3063 class=n-a></a>Shasthry SM, Sharma MK, Shasthry V, <i> et al.</i>: Efficacy of Granulocyte Colony-stimulating Factor in the Management of Steroid-Nonresponsive Severe Alcoholic Hepatitis: A Double-Blind Randomized Controlled Trial. <i>Hepatology.</i> 2019; <b>70</b>(3): 80211. <a target=xrefwindow id=d56525e3074 href="http://www.ncbi.nlm.nih.gov/pubmed/30664267">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3077 href="https://doi.org/10.1002/hep.30516">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734895548">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d56525e3091 class=n-a></a>Altamirano J, Lpez-Pelayo H, Michelena J, <i> et al.</i>: Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival. <i>Hepatology.</i> 2017; <b>66</b>(6): 184253. <a target=xrefwindow id=d56525e3102 href="http://www.ncbi.nlm.nih.gov/pubmed/28646515">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3105 href="https://doi.org/10.1002/hep.29338">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727567345"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3114 class=n-a></a>Louvet A, Labreuche J, Artru F, <i> et al.</i>: Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study. <i>Hepatology.</i> 2017; <b>66</b>(5): 146473. <a target=xrefwindow id=d56525e3125 href="http://www.ncbi.nlm.nih.gov/pubmed/28459138">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3128 href="https://doi.org/10.1002/hep.29240">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727567345">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d56525e3141 class=n-a></a>Dawson DA, Grant BF, Stinson FS, <i> et al.</i>: Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. <i>Alcohol Clin Exp Res.</i> 2005; <b>29</b>(5): 84454. <a target=xrefwindow id=d56525e3152 href="http://www.ncbi.nlm.nih.gov/pubmed/15897730">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3155 href="https://doi.org/10.1097/01.alc.0000164374.32229.a2">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d56525e3164 class=n-a></a>Dawson DA, Smith SM, Saha TD, <i> et al.</i>: Comparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders. <i>Drug Alcohol Depend.</i> 2012; <b>126</b>(3): 3848. <a target=xrefwindow id=d56525e3175 href="http://www.ncbi.nlm.nih.gov/pubmed/22728044">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3178 href="https://doi.org/10.1016/j.drugalcdep.2012.05.029">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3182 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3469743">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734432160"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3191 class=n-a></a>O'Connor EA, Perdue LA, Senger CA, <i> et al.</i>: Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. <i>JAMA.</i> 2018; <b>320</b>(18): 191028. <a target=xrefwindow id=d56525e3202 href="http://www.ncbi.nlm.nih.gov/pubmed/30422198">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3205 href="https://doi.org/10.1001/jama.2018.12086">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734432160">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d56525e3218 class=n-a></a>Agabio R, Sinclair JM, Addolorato G, <i> et al.</i>: Baclofen for the treatment of alcohol use disorder: The Cagliari Statement. <i>Lancet Psychiatry.</i> 2018; <b>5</b>(12): 95760. <a target=xrefwindow id=d56525e3229 href="http://www.ncbi.nlm.nih.gov/pubmed/30413394">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3232 href="https://doi.org/10.1016/S2215-0366(18)30303-1">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733433083"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3242 class=n-a></a>Bschor T, Henssler J, Mller M, <i> et al.</i>: Baclofen for alcohol use disorder-a systematic meta-analysis. <i>Acta Psychiatr Scand.</i> 2018; <b>138</b>(3): 23242. <a target=xrefwindow id=d56525e3253 href="http://www.ncbi.nlm.nih.gov/pubmed/29888478">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3256 href="https://doi.org/10.1111/acps.12905">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733433083">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733499397"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3269 class=n-a></a>Pierce M, Sutterland A, Beraha EM, <i> et al.</i>: Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis. <i>Eur Neuropsychopharmacol.</i> 2018; <b>28</b>(7): 795806. <a target=xrefwindow id=d56525e3280 href="http://www.ncbi.nlm.nih.gov/pubmed/29934090">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3283 href="https://doi.org/10.1016/j.euroneuro.2018.03.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733499397">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732762172"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3296 class=n-a></a>Rose AK, Jones A: Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis. <i>Addiction.</i> 2018; <b>113</b>(8): 1396406. <a target=xrefwindow id=d56525e3304 href="http://www.ncbi.nlm.nih.gov/pubmed/29479827">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3307 href="https://doi.org/10.1111/add.14191">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732762172">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718387190"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3320 class=n-a></a>Jonas DE, Amick HR, Feltner C, <i> et al.</i>: Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. <i>JAMA.</i> 2014; <b>311</b>(18): 1889900. <a target=xrefwindow id=d56525e3331 href="http://www.ncbi.nlm.nih.gov/pubmed/24825644">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3334 href="https://doi.org/10.1001/jama.2014.3628">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718387190">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727489102"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3347 class=n-a></a>Parker R, Im G, Jones F, <i> et al.</i>: Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study. <i>J Gastroenterol.</i> 2017; <b>52</b>(11): 1192200. <a target=xrefwindow id=d56525e3358 href="http://www.ncbi.nlm.nih.gov/pubmed/28389732">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3361 href="https://doi.org/10.1007/s00535-017-1336-z">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3365 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5666044">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727489102">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d56525e3378 class=n-a></a>Mookerjee RP, Stadlbauer V, Lidder S, <i> et al.</i>: Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. <i>Hepatology.</i> 2007; <b>46</b>(3): 83140. <a target=xrefwindow id=d56525e3389 href="http://www.ncbi.nlm.nih.gov/pubmed/17680644">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3392 href="https://doi.org/10.1002/hep.21737">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d56525e3402 class=n-a></a>Boussif A, Rolas L, Weiss E, <i> et al.</i>: Impaired intracellular signaling, myeloperoxidase release and bactericidal activity of neutrophils from patients with alcoholic cirrhosis. <i>J Hepatol.</i> 2016; <b>64</b>(5): 10418. <a target=xrefwindow id=d56525e3413 href="http://www.ncbi.nlm.nih.gov/pubmed/26719020">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3416 href="https://doi.org/10.1016/j.jhep.2015.12.005">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727162678"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3425 class=n-a></a>Vergis N, Atkinson SR, Knapp S, <i> et al.</i>: In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA. <i>Gastroenterology.</i> 2017; <b>152</b>(5): 10681077.e4. <a target=xrefwindow id=d56525e3436 href="http://www.ncbi.nlm.nih.gov/pubmed/28043903">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3439 href="https://doi.org/10.1053/j.gastro.2016.12.019">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3443 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6381387">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727162678">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d56525e3456 class=n-a></a>Louvet A, Wartel F, Castel H, <i> et al.</i>: Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. <i>Gastroenterology.</i> 2009; <b>137</b>(2): 5418. <a target=xrefwindow id=d56525e3467 href="http://www.ncbi.nlm.nih.gov/pubmed/19445945">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3470 href="https://doi.org/10.1053/j.gastro.2009.04.062">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d56525e3479 class=n-a></a>Lahmer T, Messer M, Schwerdtfeger C, <i> et al.</i>: Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis. <i>Mycopathologia.</i> 2014; <b>177</b>(34): 1937. <a target=xrefwindow id=d56525e3490 href="http://www.ncbi.nlm.nih.gov/pubmed/24710759">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3493 href="https://doi.org/10.1007/s11046-014-9740-x">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d56525e3502 class=n-a></a>Michelena J, Altamirano J, Abraldes JG, <i> et al.</i>: Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. <i>Hepatology.</i> 2015; <b>62</b>(3): 76272. <a target=xrefwindow id=d56525e3513 href="http://www.ncbi.nlm.nih.gov/pubmed/25761863">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3516 href="https://doi.org/10.1002/hep.27779">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3520 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4549175">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d56525e3529 class=n-a></a>Mendenhall C, Bongiovanni G, Goldberg S, <i> et al.</i>: VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. <i>JPEN J Parenter Enteral Nutr.</i> 1985; <b>9</b>(5): 5906. <a target=xrefwindow id=d56525e3540 href="http://www.ncbi.nlm.nih.gov/pubmed/3930765">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3543 href="https://doi.org/10.1177/0148607185009005590">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d56525e3553 class=n-a></a>Mendenhall CL, Tosch T, Weesner RE, <i> et al.</i>: VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition. <i>Am J Clin Nutr.</i> 1986; <b>43</b>(2): 2138. <a target=xrefwindow id=d56525e3564 href="http://www.ncbi.nlm.nih.gov/pubmed/3080866">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3567 href="https://doi.org/10.1093/ajcn/43.2.213">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d56525e3576 class=n-a></a>Moreno C, Deltenre P, Senterre C, <i> et al.</i>: Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids. <i>Gastroenterology.</i> 2016; <b>150</b>(4): 903910.e8. <a target=xrefwindow id=d56525e3587 href="http://www.ncbi.nlm.nih.gov/pubmed/26764182">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3590 href="https://doi.org/10.1053/j.gastro.2015.12.038">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d56525e3599 class=n-a></a>Zhong W, McClain CJ, Cave M, <i> et al.</i>: The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. <i>Am J Physiol Gastrointest Liver Physiol.</i> 2010; <b>298</b>(5): G625G633. <a target=xrefwindow id=d56525e3610 href="http://www.ncbi.nlm.nih.gov/pubmed/20167873">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3613 href="https://doi.org/10.1152/ajpgi.00350.2009">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3617 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2867425">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727349374"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3626 class=n-a></a>Carey EJ, Lai JC, Wang CW, <i> et al.</i>: A multicenter study to define sarcopenia in patients with end-stage liver disease. <i>Liver Transpl.</i> 2017; <b>23</b>(5): 62533. <a target=xrefwindow id=d56525e3637 href="http://www.ncbi.nlm.nih.gov/pubmed/28240805">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3640 href="https://doi.org/10.1002/lt.24750">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3644 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5762612">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727349374">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d56525e3657 class=n-a></a>Kulkarni SS, Chen H, Josbeno DA, <i> et al.</i>: Gait Speed and Grip Strength Are Associated With Dropping Out of the Liver Transplant Waiting List. <i>Transplant Proc.</i> 2019; <b>51</b>(3): 7947. <a target=xrefwindow id=d56525e3668 href="http://www.ncbi.nlm.nih.gov/pubmed/30739717">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3671 href="https://doi.org/10.1016/j.transproceed.2019.01.030">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d56525e3680 class=n-a></a>Dunn MA, Josbeno DA, Tevar AD, <i> et al.</i>: Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization. <i>Am J Gastroenterol.</i> 2016; <b>111</b>(12): 176875. <a target=xrefwindow id=d56525e3691 href="http://www.ncbi.nlm.nih.gov/pubmed/27575708">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3694 href="https://doi.org/10.1038/ajg.2016.336">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d56525e3704 class=n-a></a>Lai JC, Rahimi RS, Verna EC, <i> et al.</i>: Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. <i>Gastroenterology.</i> 2019; <b>156</b>(6): 167582. <a target=xrefwindow id=d56525e3715 href="http://www.ncbi.nlm.nih.gov/pubmed/30668935">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3718 href="https://doi.org/10.1053/j.gastro.2019.01.028">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6475483">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d56525e3731 class=n-a></a>Wells JT, Said A, Agni R, <i> et al.</i>: The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation. <i>Liver Transpl.</i> 2007; <b>13</b>(12): 172835. <a target=xrefwindow id=d56525e3742 href="http://www.ncbi.nlm.nih.gov/pubmed/18044757">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3745 href="https://doi.org/10.1002/lt.21298">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d56525e3754 class=n-a></a>McCallum S, Masterton G: Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria. <i>Alcohol Alcohol.</i> 2006; <b>41</b>(4): 35863. <a target=xrefwindow id=d56525e3762 href="http://www.ncbi.nlm.nih.gov/pubmed/16636009">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3765 href="https://doi.org/10.1093/alcalc/agl033">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d56525e3774 class=n-a></a>Pfitzmann R, Schwenzer J, Rayes N, <i> et al.</i>: Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. <i>Liver Transpl.</i> 2007; <b>13</b>(2): 197205. <a target=xrefwindow id=d56525e3785 href="http://www.ncbi.nlm.nih.gov/pubmed/17205563">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3788 href="https://doi.org/10.1002/lt.20934">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d56525e3797 class=n-a></a>DiMartini A, Dew MA, Day N, <i> et al.</i>: Trajectories of alcohol consumption following liver transplantation. <i>Am J Transplant.</i> 2010; <b>10</b>(10): 230512. <a target=xrefwindow id=d56525e3808 href="http://www.ncbi.nlm.nih.gov/pubmed/20726963">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3811 href="https://doi.org/10.1111/j.1600-6143.2010.03232.x">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3815 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3040647">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d56525e3824 class=n-a></a>de Gottardi A, Spahr L, Gelez P, <i> et al.</i>: A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. <i>Arch Intern Med.</i> 2007; <b>167</b>(11): 11838. <a target=xrefwindow id=d56525e3835 href="http://www.ncbi.nlm.nih.gov/pubmed/17563028">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3838 href="https://doi.org/10.1001/archinte.167.11.1183">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13408982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3848 class=n-a></a>Mathurin P, Moreno C, Samuel D, <i> et al.</i>: Early liver transplantation for severe alcoholic hepatitis. <i>N Engl J Med.</i> 2011; <b>365</b>(19): 1790800. <a target=xrefwindow id=d56525e3859 href="http://www.ncbi.nlm.nih.gov/pubmed/22070476">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3862 href="https://doi.org/10.1056/NEJMoa1105703">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13408982">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d56525e3875 class=n-a></a>Im GY, Kim-Schluger L, Shenoy A, <i> et al.</i>: Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States--A Single-Center Experience. <i>Am J Transplant.</i> 2016; <b>16</b>(3): 8419. <a target=xrefwindow id=d56525e3886 href="http://www.ncbi.nlm.nih.gov/pubmed/26710309">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3889 href="https://doi.org/10.1111/ajt.13586">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726410781"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3898 class=n-a></a>Lee BP, Chen PH, Haugen C, <i> et al.</i>: Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis. <i>Ann Surg.</i> 2017; <b>265</b>(1): 209. <a target=xrefwindow id=d56525e3909 href="http://www.ncbi.nlm.nih.gov/pubmed/27280501">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3912 href="https://doi.org/10.1097/SLA.0000000000001831">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726410781">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733048654"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3925 class=n-a></a>Lee BP, Mehta N, Platt L, <i> et al.</i>: Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis. <i>Gastroenterology.</i> 2018; <b>155</b>(2): 422430.e1. <a target=xrefwindow id=d56525e3936 href="http://www.ncbi.nlm.nih.gov/pubmed/29655837">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3939 href="https://doi.org/10.1053/j.gastro.2018.04.009">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3943 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6460480">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733048654">F1000 Recommendation</a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735578069"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3956 class=n-a></a>Lee BP, Samur S, Dalgic OO, <i> et al.</i>: Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis. <i>Gastroenterology.</i> 2019; <b>157</b>(2): 472480.e5. <a target=xrefwindow id=d56525e3967 href="http://www.ncbi.nlm.nih.gov/pubmed/30998988">PubMed Abstract </a> | <a target=xrefwindow id=d56525e3970 href="https://doi.org/10.1053/j.gastro.2019.04.012">Publisher Full Text </a> | <a target=xrefwindow id=d56525e3974 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6650344">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735578069">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734655639"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d56525e3987 class=n-a></a>Lee BP, Vittinghoff E, Hsu C, <i> et al.</i>: Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score. <i>Hepatology.</i> 2019; <b>69</b>(4): 147787. <a target=xrefwindow id=d56525e3998 href="http://www.ncbi.nlm.nih.gov/pubmed/30561766">PubMed Abstract </a> | <a target=xrefwindow id=d56525e4001 href="https://doi.org/10.1002/hep.30478">Publisher Full Text </a> | <a target=xrefwindow id=d56525e4005 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6453818">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734655639">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 10 Feb 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-97&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-97&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Division of Gastroenterology and Hepatology, Starzl Transplantation Institute, and Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, 15213, USA<br/> <p> <div class=margin-bottom> Vikrant Rachakonda <br/> <span>Roles: </span> Conceptualization, Investigation, Writing  Original Draft Preparation </div> <div class=margin-bottom> Ramon Bataller <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Andres Duarte-Rojo <br/> <span>Roles: </span> Conceptualization, Investigation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-97/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 10 Feb 2020, 9:97 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.20394.1">https://doi.org/10.12688/f1000research.20394.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2020 Rachakonda V <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=22413 data-id=20394 data-downloads="" data-views="" data-scholar="10.12688/f1000research.20394.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-97/v1/pdf?article_uuid=6062ef8c-8239-4c05-b625-ea3134cb710f" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.20394.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Rachakonda V, Bataller R and Duarte-Rojo A. Recent advances in alcoholic hepatitis [version 1; peer review: 3 approved] <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):97 (<a href="https://doi.org/10.12688/f1000research.20394.1" target=_blank>https://doi.org/10.12688/f1000research.20394.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=20394 id=mobile-track-article-signin-20394 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/20394?target=/articles/9-97"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=22413 /> <input name=articleId type=hidden value=20394 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Suthat Liangpunsakul</strong>, Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Sandeep Singh Sidhu</strong>, Department of Gastroenterology, Dayanand Medical College and Hospital, India </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Philip Augustine</strong>, Department of Gastroenterology, Cochin Gastroenterology Group, Ernakulam Medical Centre, India </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 10 Feb 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-97&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-97&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=63535-59592></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=63533-59594></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=63539-59593></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-97/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>10 Feb 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Suthat Liangpunsakul</strong>, Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Sandeep Singh Sidhu</strong>, Department of Gastroenterology, Dayanand Medical College and Hospital, India </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Philip Augustine</strong>, Department of Gastroenterology, Cochin Gastroenterology Group, Ernakulam Medical Centre, India </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-97&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-97/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in alcoholic hepatitis".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-97/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-97/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-97/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Rachakonda V et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-97/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-97",
            templates : {
                twitter : "Recent advances in alcoholic hepatitis. Rachakonda V et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-97/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in alcoholic hepatitis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in alcoholic hepatitis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/20394/22413")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "22413");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "59592": 0,
                           "59593": 0,
                           "59594": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "039703c7-a502-49fa-b6a1-636517acf979";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-97.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-97.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-97.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-97.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-97.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>